My Account Log in

1 option

Pharmacotherapy of diabetes: new developments : improving life and prognosis for diabetic patients / edited by Carl Erik Mogensen.

Holman Biotech Commons RC660.A1 P43 2007
Loading location information...

Available This item is available for access.

Log in to request item
Format:
Book
Contributor:
Mogensen, Carl Erik.
Language:
English
Subjects (All):
Diabetes--Chemotherapy.
Diabetes.
Diabetes Mellitus--drug therapy.
Insulin--therapeutic use.
Hypoglycemic Agents--therapeutic use.
Medical Subjects:
Diabetes Mellitus--drug therapy.
Insulin--therapeutic use.
Hypoglycemic Agents--therapeutic use.
Physical Description:
xv, 289 pages : illustrations ; 26 cm
Place of Publication:
New York : Springer, 2007.
Summary:
In the United States, 20.8 million children and adults, 7% of the population, have diabetes. While an estimated 14.6 million have been diagnosed, 6.2 million have yet to be diagnosed. Worldwide diabetes afflicts 150 million people. The World Health Organization estimates that by 2025 that figure will double. Diabetes is responsible for more deaths than AIDS and breast cancer, combined. It is a leading cause of blindness, kidney failure, amputations, heart complications and stroke.
Treatment of Type 1 and Type 2 diabetes has changed radically over the past few years. There are new opportunities for treating the key abnormality in diabetes, increased blood glucose, by effective agents such as new insulin preparations and oral agents. Increasing so-called non-glycemic intervention is of prime importance. Blood pressure lowering therapies, anti-cholesterol strategies, and specific treatment related to complications is becoming increasingly important. Pharmacotherapy of Diabetes: New Developments is a unique, invaluable guide to all aspects of the pharmacological treatment of diabetes, covering basic concepts and an in-depth review of current and future therapies. This work provides an overview for the new changes in therapies that can be implemented in clinical practice and treatment of the diabetic patient.
Contents:
Section: Dedication and Introduction / Carl Erik Mogensen v
Aperitif / Edwin Gate, UK vii
Section: Overview
1 Pharmacoepidemiology of Diabetes / Jorgen Rungby, Andrew J. Krentz 3
2 New Definitions of Diabetes: Consequences / Knut Borch-Johnsen 9
Section: Pharmacotherapy of Diabetes
3 The Insulin Resistance Syndrome: Concept and Therapeutic Approaches / Gerald M. Reaven 19
4 Medical Emergencies - Diabetic Ketoacidosis and Hyperosmolar Hyperglycaemia / Niels Moller, K. George M.M. Alberti 31
5 Notes on the Use of Glucagon in Type 1 Diabetes / Carl Erik Mogensen 39
6 Insulin and New Insulin Analogues, Insulin Pumps and Inhaled Insulin in Type 1 Diabetes / Kjeld Hermansen 41
7 Insulin and New Insulin Analogues with Focus on Type 2 Diabetes / Sten Madsbad 53
8 The Place of Insulin Secretagogues in the Treatment of Type 2 Diabetes in the Twenty-First Century / Harald Stingl, Guntram Schernthaner 67
9 Metformin - from Devil to Angel / Guntram Schernthaner, Gerit Holger Schernthaner 77
10 The Glitazones, Lessons so Far / Monika Shirodkar, Serge Jabbour 87
11 Antidiabetic Combination Therapy / Henning Beck-Nielsen, Jan Erik Henriksen 99
12 The Incretin Modulators - Incretin Mimetics (GLP-1 Receptor Agonists) and Incretin Enhancers (DPP-4 Inhibitors) / Michael A. Nauck, Wolfgang E. Schmidt, Juris J. Meier 111
13 The Role of Alpha-Glucosidase Inhibitors (Acarbose) / Markolf Hanefeld, Frank Schaper 143
14 Multifactorial Intervention in Type 2 Diabetes / Oluf Pedersen 153
Section: Treating the Comorbid Patient
15 Obesity and Pharmacological Treatment / Bjorn Richelsen 167
16 Management of Diabetic Dyslipidaemia / D. John Betteridge 173
17 Coronary Intervention and Ischemic Cardioprotection in Diabetic Patients / Torsten Toftegaard Nielsen 187
Section: Diabetic Complications and Side-effects
18 ACE-I and ARB and Blood Pressure Lowering, Including Effect on Renal Disease. Treatment of Advanced Diabetic Renal Disease / Per Logstrup Poulsen, Johan V. Poulsen 201
19 Aspirin and Antiplatelet Drugs in the Prevention of Cardiovascular Complications of Diabetes / Alberto Zanchetti 211
20 Glycosylation Inhibitors, PKC Inhibitors and Related Interventions Against Complications / Aino Soro-Paavonen, Mark Cooper 219
21 Diabetic Foot Ulcers / Andrew Boulton, Frank Bowling 229
22 Pharmacotherapy in Diabetic Neuropathy / Anders Dejgaard, Jannik Hilsted 237
23 Pregnancy - Pharmacological Problems / Elisabeth R. Mathiesen, Peter Damm 249
24 Pharmacotherapy of Diabetic Retinopathy / Toke Bek 255
25 Pharmacotherapy in Diabetic Sexual Dysfunction / Niels Ejskjaer 261
26 A Bone Perspective / Lars Rejnmark 267
Section: Notes from Major Pharmaceutical Companies (all major companies asked to participate)
27 Achieving Guideline Control with New Pharmacotherapies: Albumin-Binding by Acylation of Insulin and GLP-1 / Mads Krogsgaard Thomsen 273
28 Pharmacotherapy of Diabetes / Post Scriptum by the Editor 277.
Notes:
Includes bibliographical references and index.
ISBN:
0387697365
9780387697369
OCLC:
123374509

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account